Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Methylglyoxal”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableUnknownNCT02548741
What this trial is testing

Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
University of Arizona 120
Not applicableStudy completedNCT06603480
What this trial is testing

Effects of Exercise and Metformin on Methylglyoxal Levels in Prediabetic Individuals

Who this might be right for
MethylglyoxalPreDiabetesExercise+1 more
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 96
Not applicableStudy completedNCT05350553
What this trial is testing

Methylglyoxal Evaluation in Humans

Who this might be right for
Type 2 DiabetesNeuropathy, PainfulChronic Low-back Pain+1 more
University of Kansas Medical Center 39
Not applicableStudy completedNCT06376240
What this trial is testing

The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesMicrovascular FunctionRetinopathy, Diabetic+2 more
Maastricht University Medical Center 40
Testing effectiveness (Phase 2)WithdrawnNCT05083546
What this trial is testing

Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese Individuals

Who this might be right for
ObesityAging
University of California, San Francisco
Not applicableLooking for participantsNCT07729683
What this trial is testing

Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating Concentrations of Advanced Glycation End Products in Patients With Stage III Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Groupe Hospitalier de la Rochelle Ré Aunis 30